D

Dr.Umesh Laddi's Med-Chemist

Do regularly update on FDA approvals, clinical trials, new
drugs, side effects, drug discovery, synthetic chemistry,
med, chemist,

  • Rated2.5/ 5
  • Updated 1 Year Ago

FDA Approves Relyvrio (sodium phenylbutyrate/taurursodiol) for Patients with Amyotrophic Lateral Sclerosis (ALS)

Updated 2 Years Ago